Research field (2)：
Biomedical engineering
, Allergies and connective tissue disease
Research theme for competitive and other funds (2)：
2022 - 2025 Improvement of the therapeutic apheresis and development of new therapeutic membranes for refractory connective tissue disease focusing on the elimination of extracellular vesicles
アフェレシス療法でのcirculating microRNA除去と治療応用の研究
Papers (51)：
Taiga Kuga, Asako Chiba, Goh Murayama, Kosuke Hosomi, Tomoya Nakagawa, Yoshiyuki Yahagi, Daisuke Noto, Makio Kusaoi, Fuminori Kawano, Ken Yamaji, et al. Enhanced GATA4 expression in senescent systemic lupus erythematosus monocytes promotes high levels of IFNα production. Frontiers in immunology. 2024. 15. 1320444-1320444
Toshio Kawamoto, Michihiro Ogasawara, Go Murayama, Yuko Matsuki-Muramoto, Eri Hayashi, Mariko Harada, Makio Kusaoi, Masakazu Matsushita, Ken Yamaji, Naoto Tamura. Transitions in vascular ultrasonography findings of temporal arteritis in a GCA case with progressive temporal headache and visual impairment. Modern rheumatology case reports. 2023
Yuko Asanuma, Kazuhisa Nozawa, Masakazu Matsushita, Makio Kusaoi, Yoshiyuki Abe, Ken Yamaji, Naoto Tamura. Critical role of lectin pathway mediated by MBL-associated serine proteases in complement activation for the pathogenesis in systemic lupus erythematosus. Heliyon. 2023. 9. 8. e19072
Aya Kawasaki, Premita Ari Kusumawati, Yuka Kawamura, Yuya Kondo, Makio Kusaoi, Hirofumi Amano, Yasuyoshi Kusanagi, Kenji Itoh, Takashi Fujimoto, Naoto Tamura, et al. Genetic dissection of HLA-DRB1*15:01 and XL9 region variants in Japanese patients with systemic lupus erythematosus: primary role for HLA-DRB1*15:01. RMD OPEN. 2023. 9. 2
